Institutional members access full text with Ovid®

Possible heart failure with pramipexole use

Aschenbrenner, Diane S. MS, RN

AJN, American Journal of Nursing: January 2013 - Volume 113 - Issue 1 - p 23
doi: 10.1097/01.NAJ.0000425748.73429.18
Drug Watch

* The Parkinson's disease drug pramipexole (Mirapex) may increase the risk of heart failure.

* The Food and Drug Administration will release more information as data from additional investigation are collected and analyzed.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: daschen1@jhu.com.

© 2013 Lippincott Williams & Wilkins, Inc.